210 related articles for article (PubMed ID: 28347244)
1. The miR-30 family: Versatile players in breast cancer.
Yang SJ; Yang SY; Wang DD; Chen X; Shen HY; Zhang XH; Zhong SL; Tang JH; Zhao JH
Tumour Biol; 2017 Mar; 39(3):1010428317692204. PubMed ID: 28347244
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.
Zhu Y; Wang Q; Xia Y; Xiong X; Weng S; Ni H; Ye Y; Chen L; Lin J; Chen Y; Niu H; Chen X; Lin Y
BMC Cancer; 2020 Jul; 20(1):644. PubMed ID: 32650755
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as Biomarker for Breast Cancer.
Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
[TBL] [Abstract][Full Text] [Related]
4. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.
Najjary S; Mohammadzadeh R; Mokhtarzadeh A; Mohammadi A; Kojabad AB; Baradaran B
Gene; 2020 May; 738():144453. PubMed ID: 32035242
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer.
García-Vázquez R; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; Meneses-García A; Arce-Salinas C; Bargallo-Rocha E; Carlos-Reyes Á; López-González JS; Pérez-Plasencia C; Ramos-Payán R; Aguilar-Medina M; López-Camarillo C
Technol Cancer Res Treat; 2019 Jan; 18():1533033819827309. PubMed ID: 30755102
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
11. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
12. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Naser Al Deen N; Nassar F; Nasr R; Talhouk R
Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
[TBL] [Abstract][Full Text] [Related]
13. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
Sheikholeslami A; Nabiuni M; Arefian E
Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
[TBL] [Abstract][Full Text] [Related]
14. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract][Full Text] [Related]
15. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
16. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
18. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
